CEO
Uday Baldota
Employees
1,339
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
established in 1950, taro pharmaceutical industries ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. taro’s research programs and niche strategy have enabled the company to achieve gross margins that are among the highest in the specialty pharmaceutical sector.
Loading...
Open
42.97
Mkt cap
1.6B
Volume
147K
High
42.98
P/E Ratio
30.05
52-wk high
45.76
Low
42.94
Div yield
N/A
52-wk low
32.67
Portfolio Pulse from
November 08, 2024 | 12:15 pm
Portfolio Pulse from
November 07, 2024 | 12:15 pm
Portfolio Pulse from
November 05, 2024 | 12:30 pm
Portfolio Pulse from Benzinga Newsdesk
May 23, 2024 | 11:56 am
Portfolio Pulse from Benzinga Newsdesk
May 20, 2024 | 9:16 pm
Portfolio Pulse from Benzinga Newsdesk
January 30, 2024 | 12:07 pm
Portfolio Pulse from Benzinga Newsdesk
January 25, 2024 | 10:07 pm
Portfolio Pulse from Benzinga Newsdesk
January 25, 2024 | 10:07 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.